SCHEMBL17149263

SCHEMBL17149263

O=Cc1cc(CS)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.41
ERN1 O75460 7/20 0.38
CDK1 P06493 1/20 0.38
FOLH1 Q04609 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854721 0.80 LMNA (0.38) ERN1CDK1
SCHEMBL25457596 0.80 LOXL2 (0.41) ERN1CDK1
SCHEMBL12703942 0.80 CYP4F2 (0.46) ERN1CDK1
SCHEMBL2140724 0.77 CDK1 (0.47) ERN1CDK1TDP1
SCHEMBL13767859 0.76 ALDH1A1 (0.43) IDO1ERN1CDK1FOLH1
SCHEMBL18826911 0.76 ERN1 (0.35) ERN1CDK1
SCHEMBL28052832 0.76 ENPP2 (0.39) ERN1CDK1TDP1
SCHEMBL20238766 0.76 ERN1 (0.46) ERN1CDK1
SCHEMBL4083143 0.73 IDO1 (0.52) IDO1
SCHEMBL2541671 0.73 CDK1 (0.51) CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9955689-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-01 US disclosed
US-9894901-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-15 US disclosed
US-20150282482-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH FGF2, BROX, BOLA2; BOLA2B IDO1 1877/4885ERN1 4138/4885CDK1 3555/4885
US-20150282482-A1 METHOD FOR PROMOTING PLANT GROWTH BOLA2; BOLA2B, BROX, TET1 IDO1 1721/4885ERN1 3443/4885CDK1 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.